Otsuka Pharmaceutical Co Ltd has reached an agreement to acquire Astex Pharmaceuticals Inc, which has an oncology portfolio as well as fragment-based drug discovery technology. The deal is valued at $866 million. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
